Friday, July 17

Browsing: UnderRepresented

Treatments

02 Ten-Year Outcomes of Hypofractionated Breast/Chest Wall Radiotherapy With Simultaneous Integrated Boost (SIB) in Patients Under-Represented on Clinical Trials

By NewsCancerJuly 17, 20260

BackgroundHypofractionated breast radiotherapy is standard, yet pivotal trials under-enrolled patients with factors linked to higher toxicity risk (younger age, non-White…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

RCAF for patient-level thyroid ultrasound malignancy prediction under leakage-free evaluation and calibration

Relapsed/Refractory Multiple Myeloma: Emerging Combination Strategies With Talquetamab

Applying Real-World Evidence to Frontline Regimen Selection in HCC

Browsing: UnderRepresented

02 Ten-Year Outcomes of Hypofractionated Breast/Chest Wall Radiotherapy With Simultaneous Integrated Boost (SIB) in Patients Under-Represented on Clinical Trials

RCAF for patient-level thyroid ultrasound malignancy prediction under leakage-free evaluation and calibration

Relapsed/Refractory Multiple Myeloma: Emerging Combination Strategies With Talquetamab

Applying Real-World Evidence to Frontline Regimen Selection in HCC

The PLAU-ITGB1-TGF-β axis orchestrates spatiotemporal reprogramming of fibroblasts at the invasive front to drive dual immunosuppressive niche and immunotherapy resistance in oral squamous cell carcinoma

RCAF for patient-level thyroid ultrasound malignancy prediction under leakage-free evaluation and calibration

Relapsed/Refractory Multiple Myeloma: Emerging Combination Strategies With Talquetamab

Applying Real-World Evidence to Frontline Regimen Selection in HCC

The PLAU-ITGB1-TGF-β axis orchestrates spatiotemporal reprogramming of fibroblasts at the invasive front to drive dual immunosuppressive niche and immunotherapy resistance in oral squamous cell carcinoma

Latest Post

RCAF for patient-level thyroid ultrasound malignancy prediction under leakage-free evaluation and calibration

Relapsed/Refractory Multiple Myeloma: Emerging Combination Strategies With Talquetamab

Applying Real-World Evidence to Frontline Regimen Selection in HCC

Subscribe to Updates

What's Hot

Browsing: UnderRepresented